Skip to main content
Crystal Denlinger, MD, Oncology, Plymouth Meeting, PA

CrystalSDenlingerMD

Oncology Plymouth Meeting, PA

Gastrointestinal Cancer, Hematologic Oncology

Senior Vice President, Chief Scientific Officer, National Comprehensive Cancer Network

Dr. Denlinger is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Denlinger's full profile

Already have an account?

  • Office

    3025 Chemical Rd
    Suite 100
    Plymouth Meeting, PA 19462
    Phone+1 267-622-6654

Summary

  • Provides oversight to NCCN’s Oncology Research Program and select Compendia products. Participates in NCCN policy and global initiatives. Practicing clinician with part-time voluntary faculty appointment at Fox Chase Cancer Center.

Education & Training

  • Temple University Hospital-Fox Chase Cancer Center
    Temple University Hospital-Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 2004 - 2007
  • Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2001 - 2004
  • Rutgers New Jersey Medical School
    Rutgers New Jersey Medical SchoolClass of 2001

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2004 - 2024
  • NY State Medical License
    NY State Medical License 2002 - 2004
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Fellow American College of Physicians

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors  
    David S Hong, Marwan G Fakih, Gregory A Durm, Geoffrey I Shapiro, Gerald S Falchook, Adrian Sacher, Crystal S Denlinger, John C Krauss, Andrew L Coveler, Suresh S Rama..., The New England Journal of Medicine

Lectures

  • Impact of Health Disparities on Cancer Survivorship 
    ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/25/2020

Authored Content

  • Cardiovascular Toxicity in Cancer Survivors: Current Guidelines and Future DirectionsJune 2018

Press Mentions

  • NCCN Announces Expanded Practice Guidelines for Breast Cancer with Hereditary Risks
    NCCN Announces Expanded Practice Guidelines for Breast Cancer with Hereditary RisksDecember 13th, 2024
  • NCCN Awards Grants to Improve Care for Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
    NCCN Awards Grants to Improve Care for Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaDecember 4th, 2024
  • NCCN Guidelines Expanded to Meet Growing Understanding of Hereditary Risk
    NCCN Guidelines Expanded to Meet Growing Understanding of Hereditary RiskNovember 24th, 2024
  • Join now to see all

Grant Support

  • NCCN Foundation Young Investigator AwardNCCN Foundation2012–2014

Committees

  • Chair, NCCN Survivorship Guidelines Panel 2012 - Present
  • Member, Chemotherapy subcommittee, NCCN Esophagogastric Cancers Guidelines Panel 2009 - Present
  • Member, NCI Esophagogastric Task Force 2012 - 2013

Professional Memberships